SCHEMBL3785345

SCHEMBL3785345

CC(=O)SOc1ccc(-c2cccc(N)c2)c(N)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.36
LCK P06239 1/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
MCL1 Q07820 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAOA P21397 2/20 0.35
MAP4K4 O95819 1/20 0.35
ATM Q13315 1/20 0.34
TUBB4A P04350 2/20 0.34
TUBB P07437 2/20 0.34
TUBA3C P0DPH7 2/20 0.34
TUBA1B P68363 2/20 0.34
TUBA4A P68366 2/20 0.34
TUBB4B P68371 2/20 0.34
TUBB3 Q13509 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3790351 0.89 BRD4 (0.36) BRD4ALDH1A1MAPTKDM4EL3MBTL1
SCHEMBL3792268 0.84 CYP19A1 (0.37) ALDH1A1MAPTKDM4EMCL1SMN1; SMN2
SCHEMBL3784774 0.84 MAOA (0.44) ALDH1A1MTNR1AMTNR1BMCL1SMN1; SMN2
SCHEMBL3787833 0.83 GAPDH (0.46) ALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL3783957 0.82 MAOA (0.47) ALDH1A1MAPTMTNR1AMTNR1BMCL1
SCHEMBL3787831 0.82 ALDH1A1 (0.41) BRD4ALDH1A1MAPTKDM4E
SCHEMBL5045614 0.81 ALDH1A1 (0.39) BRD4ALDH1A1MAPTKDM4EL3MBTL1
SCHEMBL3781473 0.80 TUBB4A (0.40) BRD4ALDH1A1MAPTKDM4EL3MBTL1
SCHEMBL3784621 0.79 MAP4K4 (0.39) BRD4ALDH1A1MAPTKDM4EL3MBTL1
SCHEMBL3789932 0.78 MAOA (0.42) ALDH1A1MTNR1AMTNR1BMCL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 BRD4 96/4885LCK 631/4885ALDH1A1 4339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.